Better Therapeutics (BTTX) Insider Trading & Ownership $0.0001 0.00 (0.00%) As of 03:32 PM Eastern Add Compare Share Share Insider Trades Stock AnalysisChartCompetitorsInsider TradesOptions ChainSEC FilingsShort InterestTrendsBuy This Stock Better Therapeutics (NASDAQ:BTTX) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage51.40%Number OfInsiders Buying(Last 3 Years)7Amount OfInsider Buying(Last 3 Years)$1.84MNumber OfInsiders Selling(Last 3 Years)0 Get BTTX Insider Trade Alerts Want to know when executives and insiders are buying or selling Better Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address BTTX Insider Buying and Selling by Quarter Better Therapeutics Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame Start Date End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails7/27/2023Andrew J ArmaninoDirectorBuy274,010$0.73$200,027.30 7/27/2023David P PerryChairmanBuy1,233,045$0.73$900,122.85 7/27/2023Frank KarbeCEOBuy137,005$0.73$100,013.65 7/27/2023Mark A BermanInsiderBuy54,802$0.73$40,005.46 5/16/2023Elder GrangerDirectorBuy600$0.87$522.00 4/10/2023Frank KarbeInsiderBuy242,424$0.82$198,787.68 4/10/2023Geoffrey M ParkerDirectorBuy303,030$0.82$248,484.60 9/15/2022Frank KarbeInsiderBuy50,000$2.09$104,500.00 9/12/2022Mark HeinenInsiderBuy23,868$1.94$46,303.92 (Data available from 1/1/2013 forward) BTTX Insider Trading Activity - Frequently Asked Questions Who is on Better Therapeutics' Insider Roster? The list of insiders at Better Therapeutics includes Andrew J Armanino, David P Perry, Elder Granger, Frank Karbe, Geoffrey M Parker, Mark A Berman, and Mark Heinen. Learn more on insiders at BTTX. What percentage of Better Therapeutics stock is owned by insiders? 51.40% of Better Therapeutics stock is owned by insiders. Learn more on BTTX's insider holdings. Which Better Therapeutics insiders have been buying company stock? The following insiders have purchased BTTX shares in the last 24 months: Andrew J Armanino ($200,027.30), David P Perry ($900,122.85), Frank Karbe ($100,013.65), and Mark A Berman ($40,005.46). How much insider buying is happening at Better Therapeutics? Insiders have purchased a total of 1,698,862 BTTX shares in the last 24 months for a total of $1,240,169.26 bought. Better Therapeutics Key ExecutivesMr. David P. Perry M.B.A. (Age 56)Co-Founder & Executive Chairman Compensation: $260kMr. Frank L. Karbe (Age 56)CEO, Interim CFO, President & Director Compensation: $533.37kDr. Mark A. Berman M.D. (Age 48)Chief Medical Officer Compensation: $573.75kMs. Kristin Wynholds (Age 51)Chief Product Officer Compensation: $519.07kMr. Andres CamachoSenior VP of Technology & Head of EngineeringMs. Angela WillisSenior Vice President of Market AccessMs. Jessica MengChief Commercial OfficerLeslie MillerController More Insider Trading Tools from MarketBeat Related Companies AONC Insider Trades FMS Insider Trades LFMDP Insider Trades TOIIW Insider Trades NTRA Insider Trades HIMS Insider Trades GH Insider Trades OPCH Insider Trades RDNT Insider Trades BTSG Insider Trades Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles The Bottom Is in For These 3 Small-Cap Stocks Insiders Are Buying3 Catalysts Driving Plug Power’s Turnaround CaseInsider Selling Hits Market Leaders—Should You Be Worried?Insiders Spent Millions on These 3 Stocks Over the Past 2 Months3 Small Caps Drawing Insider and Institutional Support This page (NASDAQ:BTTX) was last updated on 7/24/2025 by MarketBeat.com Staff From Our PartnersElon’s BIGGEST warning yet?Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… ...Brownstone Research | SponsoredWhy Elon put $51 million into thisA single U.S. company has started producing a “miracle metal” once locked in research labs. Now? They’re qu...True Market Insiders | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredTreasury Secretary Bessent Is Betting Big on GoldWhen the U.S. Treasury Secretary’s largest personal investment is gold — that’s a signal. Now a veteran gol...Golden Portfolio | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredThink you missed gold’s boom? Think againIf you've been watching gold's historic run and wondering if it's too late… I've got good news. Because the...Investors Alley | SponsoredCritical AI announcement set to ignite AI 2.0 I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredA grave, grave error.I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Better Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Better Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free BTTX Stock Alerts